Our investigation of CRC prognosis revealed that elevated expression of CDC14A, PDK2, and UGT2A3 was significantly associated with improved overall survival, while CHAD showed similar trends without reaching statistical significance. Here, UGT2A3 is linked to colorectal carcinoma.